¹ú²ú³Ô¹Ï

Wanbury Ltd is a pharmaceutical company known for its focus on producing high-quality active pharmaceutical ingredients (APIs) and formulations. The company serves both domestic and international markets, offering products that cater to a variety of therapeutic areas. Wanbury is committed to innovation and affordability, striving to make healthcare accessible to all. Wanbury Share Price on NSE as of 26 December 2024 is 271.23 INR. Here will provide you more details on Wanbury Share Price Target 2024, 2025, 2026 to 2030.

Wanbury Ltd: Market Overview

• Open: ₹270.00
• High: ₹274.56
• Low: ₹266.56
• Previous Close: ₹270.67
• Volume: 31,377
• Value (Lacs): ₹85.35
• VWAP: ₹269.47
• P/E ratio: 17.27
• UC Limit: ₹284.20
• LC Limit: ₹257.13
• 52 Week High: ₹323.53
• 52 Week Low: ₹123.00
• Mkt Cap (Rs. Cr.): ₹891
• Face Value: ₹10

Wanbury Share Price Chart

Wanbury Share Price Target Tomorrow 2024 To 2030

Wanbury Share Price Target 2024

Wanbury share price target 2024 Expected target could be ₹325. Here are four key factors that could affect Wanbury Ltd’s share price target for 2024:

1. Rising Demand for Pharmaceuticals: Increasing healthcare needs, both domestically and internationally, can drive demand for Wanbury’s APIs and formulations, boosting revenue growth.
2. Product Portfolio Expansion: Introducing new drugs or expanding into high-demand therapeutic areas could help Wanbury capture a larger market share and attract new clients.
3. Export Opportunities: Strengthening its presence in global markets, particularly in regulated regions like the US and Europe, can enhance the company’s revenue and profitability.

4. Cost Efficiency and Innovation: Improving operational efficiency and focusing on innovative, cost-effective production methods can help Wanbury remain competitive and sustain growth.

Wanbury Share Price Target 2025

Wanbury share price target 2025 Expected target could be ₹475. Here are four key factors that could affect Wanbury Ltd’s share price target for 2025:

1. Regulatory Approvals and Partnerships: Securing approvals for new drugs and forming strategic partnerships with global pharmaceutical companies could enhance Wanbury’s market reach and boost growth prospects.
2. Focus on R&D and Innovation: Continued investment in research and development to create new formulations or improve existing products can give Wanbury a competitive edge, attracting more customers and increasing revenue.
3. Expansion in Emerging Markets: Strengthening its presence in fast-growing emerging markets, where healthcare needs are rising, could provide significant growth opportunities for Wanbury.

4. Cost Control and Supply Chain Efficiency: Effective cost management and improvements in the supply chain can help the company maintain healthy profit margins, making it more attractive to investors.

Wanbury Share Price Target 2030

Wanbury share price target 2030 Expected target could be ₹1225. Here are four risks and challenges that could impact Wanbury Ltd’s share price target for 2030:

1. Regulatory and Compliance Risks: Stringent regulatory requirements in different countries could delay product approvals, increase compliance costs, or restrict market access, impacting growth.
2. Intense Competition: The pharmaceutical industry is highly competitive, and the emergence of generic drug manufacturers or new innovative companies could pressure Wanbury’s market share and profit margins.
3. Raw Material Price Fluctuations: Variability in the prices of raw materials used for production could affect the cost structure and profitability, especially if there are supply chain disruptions.

4. Intellectual Property Risks: Potential challenges to the company’s patents or intellectual property, such as legal disputes or patent expirations, could reduce its competitive advantage and revenue from existing products.

Shareholding Pattern For Wanbury Ltd

• Promoters: 39.77%
• FII: 1.02%
• Public: 59.2%

Wanbury Ltd Financials

Read Also:- Supreme Power Share Price Target Tomorrow 2024 To 2030- Market Overview, Today Chart